Jeffries L. Oliver-Li


Oliver-Li, Jeffries L.

Jeffries Oliver-Li's practice focuses on corporate and securities law matters. He represents companies in public offerings, venture capital financings and mergers and acquisitions. Mr. Oliver-Li also advises companies with respect to securities law compliance and disclosures and general corporate matters.

Mr. Oliver-Li's public company clients include Catabasis Pharmaceuticals, Inc., Editas Medicine, Inc., The First Marblehead Corporation, PerkinElmer, Inc. and Tangoe, Inc.

Mr. Oliver-Li's transactional practice has included representation of:

  • Casella Waste Systems, Inc. in its tender offer for and redemption of $195 million of senior subordinated notes;
  • Catabasis Pharmaceuticals, Inc. in its $69 million initial public offering;
  • Constellation Pharmaceuticals, Inc. in its $55 million mezzanine financing;
  • CoreStreet, Ltd. in its acquisition by ActivIdentity Corporation for $19 million;
  • Editas Medicine, Inc. in its $109 million initial public offering;
  • Netezza Corporation in its acquisition by IBM for $1.9 billion;
  • Sonus Networks, Inc. in its acquisition of Network Equipment Technologies, Inc. for $42 million;
  • Tangoe, Inc. in its $100 million initial public offering and its $170 million follow-on offering; and
  • Tetraphase Pharmaceuticals, Inc. in its $80 million initial public offering.

While in law school, Mr. Oliver-Li held a summer associate position with WilmerHale, working primarily in corporate law and litigation.

Publications & News


February 8, 2018

WilmerHale Advises on the Formation of Valence Media, a New Diversified Media Company

WilmerHale served as legal counsel in connection with the creation of Valence Media, a new diversified media company formed through the combination of three successful media companies: Billboard-Hollywood Reporter Media Group, dick clark productions and MRC.

December 29, 2017

WilmerHale Represents Arsanis in Closing of Initial Public Offering

Arsanis, Inc., a clinical-stage biopharmaceutical company focused on applying monoclonal antibody immunotherapies to address serious infectious diseases, announced the closing of its initial public offering of 4,600,000 shares of its common stock at a public offering price of $10 per share, including 600,000 additional shares of common stock issued upon the exercise in full by the underwriters of their over-allotment option.

December 21, 2017

WilmerHale Represents Casa Systems in Initial Public Offering

On December 19, 2017, Casa Systems, Inc., a provider of software-centric solutions for next-generation distributed and virtualized architectures in cable operator, fixed telecom and wireless networks, closed its initial public offering.

May 5, 2017

WilmerHale Reps Tangoe in Acquisition by Marlin Equity Partners

WilmerHale client Tangoe, Inc., a global leader in telecom expense management solutions, and Marlin Equity Partners, a global investment firm, entered into a definitive agreement for Marlin to acquire all outstanding shares of Tangoe not already owned by Marlin for $6.50 per share in cash.

December 23, 2016

WilmerHale Reps Editas Medicine in Licensing of New Technologies

Editas Medicine, Inc., a leading genome editing company, announced it has exclusively licensed intellectual property related to new CRISPR technologies for human therapeutics that will enhance and broaden the range of medicines the company can develop.

October 6, 2016

WilmerHale Advises Catabasis Pharmaceuticals in Closing of $11.5M Offering of Common Stock

The WilmerHale deal team was led by Partner Rosemary Reilly and included Counsel Jeffries Oliver-Li, Associate Timothy Kulis, and Attorney Heidi Treiber.

August 18, 2016

WilmerHale Advises Franklin Street Properties in $83M Closing of Common Stock Offering

Franklin Street Properties Corp. closed an underwritten public offering of its common stock on August 16, 2016.

July 20, 2016

WilmerHale Advises PerkinElmer in €500M Eurobond Offering

PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, announced that it has completed a public offering of €500 million aggregate principal amount of 1.875% Senior Notes due 2026 at an issue price of 99.118% of the principal amount.

June 2, 2016

WilmerHale Counsels State Street in $1.5B Debt Offering

State Street Corporation, one of the world's leading providers of financial services to institutional investors, including investment servicing, investment management and investment research and trading, recently announced a $1.5 billion debt offering.

February 3, 2016

WilmerHale Reps Editas Medicine in $94.4 Million IPO

WilmerHale represented Massachusetts-based gene editing company Editas Medicine in its $94.4 million initial public offering, which occurred on February 2, 2016.

Speaking Engagements


Skip Navigation Links.


JD, cum laude, Harvard Law School, 2006, Harvard Journal of Law & Technology

AB, History of Art & Architecture, summa cum laude, Harvard College, 2003, Phi Beta Kappa, Thomas Temple Hoopes Prize

Bar Admissions


Skip Navigation Links.